On July 27th RIWI Q2 2020 financials were released. The quarter was good but not spectacular. RIWI generated $1 million in revenue and $117,000 in net income. The numbers look…
Crescita Therapeutics is now a net-net stock. With their recent announcement of a one time payment from Taro for $5.2 million Crescita is trading at less that its net-current-asset-value. On…
After reviewing Brinks Q1 2020 conference call transcript I realized that Brinks is launching Cirreon Banking under their Brinks Complete solution. Brinks is in the midst of launching Strategy 2.0.…
On May 26th Crescita Q1 2020 results were released. Crescita was cash-flow positive without any milestone or upfront payments from Pliagis agreements. This quarter gives us a good look at…
On May 21st, 2020, CO2 Gro Q1 2020 results were released. We are starting to see revenue come in from the Missouri hemp installations but it is still early days.…
On April 20th, 2020 CO2 Gro 2019 results were released. While revenue did not grow as anticipated the company made significant progress in 2019. A major development for the company…
On April 28th, 2020, RIWI Q1 2020 financials were released. It was a record quarter for RIWI as they earned $1.3 million in revenue. This was accomplished with a 37.7%…
On March 18th, 2020, Crescita Therapeutics 2019 financials were released. It was a transformational year for Crescita. They signed a lucrative contract with Cantabria Labs for sales of Pliaglis in…
On March 5th, 2020, Riwi 2019 financial results were released. The news release can be found here. I had high hopes for RIWI in 2019, and still do. However, 2019…
NamSys Inc. Company Profile: NamSys Ticker: CTZ.V (TSXV) NMYSF (PNK)Website: NamSys.comShare Price: $1.09Market Cap: $29.7 million Shares Outstanding: 27.3 millionOptions and Warrants: NoneCash and Short Term Investments: $4.4 million Debt:…